Cargando…
TINF2 is a haploinsufficient tumor suppressor that limits telomere length
Telomere shortening is a presumed tumor suppressor pathway that imposes a proliferative barrier (the Hayflick limit) during tumorigenesis. This model predicts that excessively long somatic telomeres predispose to cancer. Here, we describe cancer-prone families with two unique TINF2 mutations that tr...
Autores principales: | Schmutz, Isabelle, Mensenkamp, Arjen R, Takai, Kaori K, Haadsma, Maaike, Spruijt, Liesbeth, de Voer, Richarda M, Choo, Seunga Sara, Lorbeer, Franziska K, van Grinsven, Emma J, Hockemeyer, Dirk, Jongmans, Marjolijn CJ, de Lange, Titia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707837/ https://www.ncbi.nlm.nih.gov/pubmed/33258446 http://dx.doi.org/10.7554/eLife.61235 |
Ejemplares similares
-
Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita
por: Choo, Seunga, et al.
Publicado: (2022) -
Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer
por: de Voer, Richarda M., et al.
Publicado: (2015) -
Tissue-specific telomere shortening and degenerative changes in a patient with TINF2 mutation and dyskeratosis congenita
por: Roake, Caitlin M., et al.
Publicado: (2021) -
Novel TINF2 gene mutation in dyskeratosis congenita with extremely short telomeres: A case report
por: Picos-Cárdenas, Verónica Judith, et al.
Publicado: (2022) -
Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome
por: Elze, Lisa, et al.
Publicado: (2023)